Allelic diversity and naturally acquired allele-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 in Kenya
about
European Vaccine Initiative: lessons from developing malaria vaccinesMeasurement of the plasma levels of antibodies against the polymorphic vaccine candidate apical membrane antigen 1 in a malaria-exposed populationEvolution of the bovine TLR gene family and member associations with Mycobacterium avium subspecies paratuberculosis infectionImmunization with different PfAMA1 alleles in sequence induces clonal imprint humoral responses that are similar to responses induced by the same alleles as a vaccine cocktail in rabbitsSerological evidence of discrete spatial clusters of Plasmodium falciparum parasitesPopulation genomic scan for candidate signatures of balancing selection to guide antigen characterization in malaria parasites.Immunization with the Malaria Diversity-Covering Blood-Stage Vaccine Candidate Plasmodium falciparum Apical Membrane Antigen 1 DiCo in Complex with Its Natural Ligand PfRon2 Does Not Improve the In Vitro Efficacy.Distinct patterns of diversity, population structure and evolution in the AMA1 genes of sympatric Plasmodium falciparum and Plasmodium vivax populations of Papua New Guinea from an area of similarly high transmissionStrategies for designing and monitoring malaria vaccines targeting diverse antigensThe breadth, but not the magnitude, of circulating memory B cell responses to P. falciparum increases with age/exposure in an area of low transmission.Limited antigenic diversity of Plasmodium falciparum apical membrane antigen 1 supports the development of effective multi-allele vaccines.Use of immunodampening to overcome diversity in the malarial vaccine candidate apical membrane antigen 1.Malaria immunoepidemiology in low transmission: correlation of infecting genotype and immune response to domains of Plasmodium falciparum merozoite surface protein 3Global Population Structure of the Genes Encoding the Malaria Vaccine Candidate, Plasmodium vivax Apical Membrane Antigen 1 (PvAMA1).New antigens for a multicomponent blood-stage malaria vaccineAntibodies to Plasmodium falciparum erythrocyte-binding antigen-175 are associated with protection from clinical malaria.Multiple clinical episodes of Plasmodium falciparum malaria in a low transmission intensity setting: exposure versus immunity.Dynamics and role of antibodies to Plasmodium falciparum merozoite antigens in children living in two settings with differing malaria transmission intensity.Molecular basis of allele-specific efficacy of a blood-stage malaria vaccine: vaccine development implicationsA full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants.Acquired immune responses to three malaria vaccine candidates and their relationship to invasion inhibition in two populations naturally exposed to malaria.Contrasting Patterns of Serologic and Functional Antibody Dynamics to Plasmodium falciparum Antigens in a Kenyan Birth CohortTargets and Mechanisms Associated with Protection from Severe Plasmodium falciparum Malaria in Kenyan Children.Overcoming allelic specificity by immunization with five allelic forms of Plasmodium falciparum apical membrane antigen 1.Comparison of allele frequencies of Plasmodium falciparum merozoite antigens in malaria infections sampled in different years in a Kenyan populationA threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria.Genetic diversity of the Plasmodium falciparum apical membrane antigen I gene in parasite population from the China-Myanmar border areaAnalysis of Pvama1 genes from China-Myanmar border reveals little regional genetic differentiation of Plasmodium vivax populations.Differing rates of antibody acquisition to merozoite antigens in malaria: implications for immunity and surveillance.A deep sequencing approach to estimate Plasmodium falciparum complexity of infection (COI) and explore apical membrane antigen 1 diversity.An engineered vaccine of the Plasmodium vivax Duffy binding protein enhances induction of broadly neutralizing antibodies.A multi-bioreactor system for optimal production of malaria vaccines with Pichia pastoris.Proteome-wide mapping of immune features onto Plasmodium protein three-dimensional structures.Unraveling Haplotype Diversity of the Apical Membrane Antigen-1 Gene in Plasmodium falciparum Populations in Thailand.Structural patterns of selection and diversity for Plasmodium vivax antigens DBP and AMA1.Extent and Dynamics of Polymorphism in the Malaria Vaccine Candidate Reticulocyte-Binding Protein Homologue-5 in Kalifabougou, Mali
P2860
Q21032652-A6B955C7-B227-4DA9-AB08-81F16F5021DDQ28730794-EBA19124-9642-4701-8F39-1F156EAD1B91Q28742123-95C832B0-6877-478F-BD87-B6A763663B64Q28742130-E34B22B3-3F46-44EB-9150-DBEB28C302AAQ28743081-A6D474B2-C82C-4DEE-8847-9F29867F5D61Q31076942-5D2311D5-70BF-457E-B828-26205E6B402EQ33835382-98AAF4B9-6155-4020-A53E-BBE6190AE9F1Q33859217-EDC65EF4-ACC7-42B8-B4DE-3E968FFFCFA5Q33959038-7067C25F-040C-4DC0-8308-D3610ADBFE18Q34047037-902D3FDF-1419-4F9A-AE8F-F0C1E2F0229DQ34416904-D569FCEF-0D6B-4FFD-91C0-54A9343C63E7Q34596157-BB09E3F0-2AB5-4112-A632-416521C56322Q34931887-C7D21D3C-81BE-4D5F-B724-0E5B556EEC22Q35037036-4AB1B73A-6C04-4D3A-A4D8-6601313381B7Q35216634-B63652B6-F5B0-48AD-83C9-CA0394CEA9E5Q35569042-B97C02E6-848C-4021-B6B2-2452D81DF0E7Q35628510-CFA5CB28-0B2D-4B76-AA1B-E7F30213B15AQ36381444-B71EA175-F292-48BD-AACF-47A290E7BC9CQ36509831-9C50B2B7-959D-4C48-84CC-73031881F837Q36511421-8C301426-33E9-4D6C-9524-43A5B43EC66DQ36550447-8FE63DA0-7522-4BA9-9A1E-D36432370F36Q36555103-D278A8C8-0E26-4B9B-A7F2-3F0A0E4B4846Q36728063-518A0634-0999-4AE5-A0C9-60572C42866CQ36826951-7D500B4B-186A-4599-9C1B-7E2349D4E458Q36875789-C4362303-5601-47DC-BE27-18CF7D9FB9A0Q37148056-EF2D51CA-6F42-4055-9EB5-0B04062C2745Q37348151-BB18910A-3C69-4184-BE0A-28F1C96EB591Q37455373-88B42FA4-3010-4491-87BB-077D73BD7E6CQ39230991-6ADB05AB-ED3D-4FF0-8FEA-ADE873E43058Q46688458-2B7ED6DC-6DBD-4B41-ACB3-5860A3675136Q47150417-37834238-74AD-42BD-8609-24692FD402C2Q47977058-36EDC1DE-58F2-4305-A93D-4F3FE6FC8475Q54257311-7FDA7F05-DF73-4DEA-83BC-DFCD2D926942Q55008319-32219A8F-A7F0-446A-B7B9-51A91FCC1B52Q55429433-92BAE8F3-4115-48B8-871B-6C100690B29FQ56369001-D22A19FD-A05B-4654-BBB3-08F17C080C21
P2860
Allelic diversity and naturally acquired allele-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 in Kenya
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Allelic diversity and naturall ...... al membrane antigen 1 in Kenya
@ast
Allelic diversity and naturall ...... al membrane antigen 1 in Kenya
@en
Allelic diversity and naturall ...... al membrane antigen 1 in Kenya
@nl
type
label
Allelic diversity and naturall ...... al membrane antigen 1 in Kenya
@ast
Allelic diversity and naturall ...... al membrane antigen 1 in Kenya
@en
Allelic diversity and naturall ...... al membrane antigen 1 in Kenya
@nl
prefLabel
Allelic diversity and naturall ...... al membrane antigen 1 in Kenya
@ast
Allelic diversity and naturall ...... al membrane antigen 1 in Kenya
@en
Allelic diversity and naturall ...... al membrane antigen 1 in Kenya
@nl
P2093
P2860
P50
P921
P356
P1476
Allelic diversity and naturall ...... al membrane antigen 1 in Kenya
@en
P2093
Alan Thomas
Ed Remarque
Federica Verra
Gareth D Weedall
Kevin K A Tetteh
Linda Murungi
P2860
P304
P356
10.1128/IAI.00576-10
P407
P577
2010-08-23T00:00:00Z